UNLOOC mitigates the use of animal testing in drug development by designing groundbreaking Organ-on-Chips technologies
The UNLOOC project (Unlocking the data content of Organ-on-Chips), launched in May 2024 in Germany, is a three-year initiative focused on creating Organ-on-Chips (OOC) technologies to reduce animal testing and bridge the gender gap in drug development. Funded by the Chips Joint Undertaking and national agencies, the project uses human cells to enhance personalized medicine and tackle gender disparities inherent in clinical research. Spinverse supported the consortium during the project proposal phase and is now taking care of the daily administration of this fascinating project.